AVROBIO Stock Price, News & Analysis
Company Description
AVROBIO (NASDAQ: AVRO) is a publicly traded biological product (except diagnostic) manufacturing company in the Biological Products, (no Disgnostic Substances) sector. The company has a market capitalization of $62.9M, ranking #5,478 among all listed U.S. companies by market cap.
AVRO stock has declined 100.0% over the past year. Shares last traded at $1.40.
This page provides a comprehensive overview of AVRO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AVROBIO (AVRO) stock last traded at $1.40. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $62.9M, AVRO is classified as a micro-cap stock with approximately 44.9M shares outstanding.
Latest News
AVROBIO has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include management, clinical trial, acquisition, earnings. View all AVRO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AVRO Company Profile & Sector Positioning
AVROBIO (AVRO) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Biological Products, (no Disgnostic Substances) sector and is listed on the NASDAQ.